OLIGOLIP

Serial Number 79381544
Registration 7435795
700

Registration Progress

Application Filed
Sep 25, 2023
Under Examination
Approved for Publication
Apr 3, 2024
Published for Opposition
Apr 23, 2024
Registered
Jul 9, 2024

Trademark Image

OLIGOLIP

Basic Information

Serial Number
79381544
Registration Number
7435795
Filing Date
September 25, 2023
Registration Date
July 9, 2024
Published for Opposition
April 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 9, 2024
Registration
Registered
Classes
005

Rights Holder

INDENA SPA

03
Address
Viale Ortles, 12
I-20139 MILANO
IT

Ownership History

INDENA SPA

Original Applicant
03
IT

INDENA SPA

Owner at Publication
03
IT

INDENA SPA

Original Registrant
03
IT

USPTO Deadlines

Next Deadline
1664 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240709)
Due Date
July 09, 2030
Grace Period Ends
January 09, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Jun 20, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Mar 18, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 18, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Aug 8, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 3, 2024 NPUB O NOTICE OF PUBLICATION Loading...
Mar 18, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 12, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 27, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 23, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 19, 2023 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Medicinal plant extracts for pharmaceutical and medical use, namely, for the treatment of metabolic system diseases such as hyperlipidaemia and hypercholesterolaemia

Classification

International Classes
005